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Abstract
The purpose of this study was to examine the effect of oral contraceptive (OC) use on salivary secretory immunoglobulin A (SIgA) levels at rest and in response to an acute bout of moderate-vigorous exercise during two phases of the 4 week OC cycle corresponding to different phases of the synthetic menstrual cycle.
Ten healthy active females completed a cycling at 70% V ・ O 2peak for 45 min at two time points of an OC cycle: during the equivalent in time to the mid-follicular phase (day 8 ± 2) and the mid-luteal phase (day 20 ± 2). Timed unstimulated saliva samples were obtained before, immediately post exercise and 1 h post exercise and analyzed for salivary SIgA.
Salivary SIgA secretion rate was 26 % (95% Confidence limits, CI, 6-46) lower at post-exercise compared with pre-exercise during the synthetic follicular phase (p = 0.019) but no differences were observed during the synthetic luteal trial. Saliva flow rate was 11% (95% CI, ) lower at post-exercise compared with pre-exercise (main effect for time; p = 0.025).
In conclusion, the pattern of salivary SIgA secretion rate response to moderate-vigorous exercise varies across the early and late phases of a monophasic OC cycle, with a transient reduction in salivary SIgA responses during the synthetic follicular phase. SIgA concentration and salivary SIgA secretion rate were decreased across a 12-month training period in American football players with salivary SIgA secretion rate found to be predictive of URS incidence. Furthermore, athletes who reported recurrent symptoms of URS had a higher training load and a lower salivary SIgA secretion rate than the symptom-free counterparts (Gleeson et al. 2012) . URS cluster around competitions and detrimentally affect performance in elite swimmers (Pyne et al. 2001) .
A recent study suggests that female athletes may be more susceptible than their male counterparts to URS (He et al. 2014) . A lower level of oral-respiratory mucosal immunity may explain this as it is reported that females present a lower salivary SIgA and it is estimated that use among female athletes at least matches that of the general population (Bennell et al. 1999) . The findings of a large study of the genito-urinary mucosal secretions of 69 OC users and 85 non-OC users suggests that both menstrual phase and OC use are significant determinants of cervical SIgA and SIgG levels, with higher levels of SIgA and SIgG in OC users at the time in the cycle equivalent to the follicular phase (the 'synthetic' follicular phase) compared with the synthetic luteal phase (Safaeian et al. 2009 ). This is despite a constant amount of synthetic oestrogen being ingested during those times. However, although not as extreme as in non-OC users, these times in the synthetic menstrual cycle also correspond to significant, albeit small, differences in levels of circulating oestrogen concentrations in OC users (Timmons et al. 2005 ). It is not known if OC have similar effects on salivary SIgA levels. Interestingly, reported incidences of the common cold were also associated with lower cervical SIgA levels (Safaeian et al. 2009 ).
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The aim of the present study was therefore to determine the effect of OC use on salivary concentrations of 17β-estradiol, progesterone and salivary SIgA at rest and salivary SIgA responses to an acute bout of moderate-vigorous exercise during two phases of the 4 week OC cycle corresponding to different phases of the synthetic menstrual cycle.
MATERIALS AND METHODS
Participants
Ten healthy regularly active (but not specifically endurance trained) females (mean ± SD: age 20.8 ± 1.7 years; height 169.9 ± 4.5 cm; body mass 63.0 ± 6.7 kg; V ・ O 2peak 43.3 ± 6.6 mL/kg/min; peak power output 224.0 ± 29.5 watts) volunteered to participate in the study. All participants had been regularly taking 21 day monophasic combined oral contraceptives (0.030-0.035 mg ethinyloestradiol and either 0.25 mg norgestimate, 0.5 mg norethisterone or 0.15 mg levonorgestrel) for at least 6 months prior to recruitment and had regular synthetic menstrual cycles.
All participants were fully informed (written and verbally) about the study and possible benefits and risks. Participants provided written consent to participate in the study which was approved by the Loughborough University Ethical Committee. At an initial health screening, participants did not report taking any other medication or experiencing symptoms of infection within the previous two weeks. All participants were non-smokers.
Preliminary procedures
In a preliminary session, peak oxygen uptake ( V ・ O 2peak ) was estimated using a continuous incremental exercise test performed on an electromagnetically braked cycle ergometer (Lode Excalibur, Groningen, Netherlands). Participants began cycling at a work rate of 35 watts, with increments of 35 watts every 3 min, continuing until volitional fatigue. Expired gas samples were collected into Douglas bags during the third minute of each work rate increment and the final minute of the exercise test, and heart rates were measured continuously using short-range telemetry (Polar FS1, Polar Electro Oy, Kempele, Finland). The percentages of O 2 and CO 2 in the expired gas samples were measured using a paramagnetic oxygen analyzer and an infrared carbon dioxide analyzer (series 1400, Servomex, Crowborough, East Sussex, UK), respectively.
These were used alongside a dry gas meter (Harvard Aparatus, Edenbridge, Kent, UK) to determine V Participants returned to the laboratory for a second occasion to undertake a familiarization period that consisted of cycling for 45 min at a work rate corresponding to 70% V ・ O 2peak . Heart rates were monitored during cycling, and 1-min expired gas samples were taken during the 15th, 30th and 45th min to ensure that the participants were exercising at the required intensity. If this was not the case, work rate was adjusted accordingly.
Main trials
Participants completed one experimental trial during the phase of the OC cycle that is equivalent in time to the mid-follicular phase (8 ± 2 days after start of menstruation) and one during the phase of the OC cycle that is equivalent in time to the mid-luteal phase (20 ± 2 days after start of menstruation). For simplicity, these will be subsequently referred to as the follicular phase and the luteal phase. To counterbalance the order in which women completed the experimental sessions, six started during the follicular phase and four during the luteal phase. This design required some women to complete all testing within one menstrual cycle, and some required testing to carry over into their next cycle.
Participants were instructed to maintain their regular exercise routines throughout the study, but no strenuous exercise was allowed during 24 h before each main trial. In an effort to standardize their nutritional status, participants were asked to eat the same foods and drinks during the 24 h prior to both experimental trials. Each participant was also asked to refrain from caffeine and alcohol intake during 24 h before each main trial.
After at least a 4 h fast, participants arrived at the laboratory at 11:45 h to ensure that timing of exercise and saliva collection was consistent across all participants and all main trials. Participants were not allowed to eat until trial was completed, but water was provided to maintain hydration during the trial.
Participants were required to empty their bladder before body mass was recorded.
Subsequently, participants sat quietly for 10 min before an initial pre-exercise (baseline) saliva sample was collected into a pre-weighted sterile plastic containers. For this, participants rinsed their mouth with water, swallowed the whole fluid in their mouth and sat still with their head slightly tilted forward with minimal orofacial movement. Following a second incubation at room temperature for 90 min and a final wash, a colour substrate (OPD substrate, Dako, Ely, UK) was added, and the absorbance of the individual samples was subsequently determined at 490 nm. Salivary SIgA secretion rate was calculated by multiplying SIgA concentration with saliva flow rate. All samples from the same participant were analyzed in duplicate on a single microplate.
The coefficient of variation of the methods on the basis of analyses of these duplicate samples was 2.2% for 17β-estradiol, 1.7% for progesterone and 2.8% for salivary SIgA.
Statistical analysis
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A student's paired t-test was used to assess the differences in basal salivary hormone levels between the follicular and luteal phases. A two-way (trial x time) analysis of variance with repeated measures was used to examine the differences in salivary SIgA levels. When a main effect was observed, post hoc tests using Bonferroni adjustment was used for multiple comparisons. Statistical significance was set at p < 0.05. Effect sizes (ES) based on eta 2 are provided for all significant data to give an indication of the proportion of the variation attributable to trial or group, using Cohen's definition of eta 2 of 0.01, 0.06 and 0.14 representing 'small', 'medium' and 'large' effects, respectively (Cohen, 1988) . Statistical analyses were performed using PASW Statistics 18 software (SPSS, Chicago, IL, USA). Data are expressed as mean ± SD.
RESULTS
Baseline salivary 17β-estradiol and progesterone concentrations in each synthetic phase are presented in Table 1 . The salivary 17β-estradiol level was significantly higher in the synthetic follicular phase compared with the synthetic luteal phase at baseline (p = 0.029, ES = 0.43) ( Table 1 ). There were no significant differences in salivary progesterone levels ( (Fig. 1c) .
DISCUSSION
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The principal finding of the present study was that the salivary SIgA secretion rate was significantly reduced by 45 min cycling at 70% V ・ O 2peak in the synthetic follicular phase
only, yet the salivary SIgA concentration was unaffected by both the phases of the OC cycle and exercise. We also report the salivary resting 17β-estradiol concentration was significantly lower in the synthetic luteal compared with the synthetic follicular phase but levels of progesterone were constant.
In the present study, there were no differences in resting saliva flow rates, salivary SIgA SIgA production is not affected by physiological variations of ovarian hormones across a single OC cycle.
To our knowledge, the present study is the first to report differences in salivary SIgA 18 secretion rate between synthetic menstrual phases in active females who use monophasic OC. In the synthetic follicular phase, salivary SIgA secretion rate fell by 26% (95% CI, 6-46) after performing 45 min moderate-vigorous intensity exercise but there was no effect of exercise on salivary SIgA secretion rate in the synthetic luteal phase. A limitation of the present study is that we did not assess the non-OC users as a control group. However, in a similar protocol to the present study, Gillum et al. (2014) found higher IgA secretion at times of higher estrogen concentrations, in contrast to the observations of the present study. However, the doses used in the study by Diebel et al.
were in the μmol/l -1 range, much larger than that seen in the circulation in OC users.
Furthermore, cortisol is known to be higher in OC users (Timmons et al., 2005) and the presence of cortisol decreases expression of pIgR mRNA in rabbit mammary gland organ culture (Rosato et al. 1995) . Although it is not clear if the same effect is present in humans, it could be speculated that an altered cortisol response to exercise between the two phases could have contributed to the altered salivary SIgA response to exercise observed here. It is acknowledged that further exploration of this theory is limited as cortisol levels were not determined in the present study. The response of the SIgA (concentration and secretion rate) to maximal incremental swimming exercise was not influenced by menstrual cycle phase in female swimmers who were non-OC users (Morgado et al. 2014 ). In contrast, the difference of the SIgA secretion rate response was observed in the OC cycle in this study. Therefore, the findings of the study provide an initial indication of the potential importance for OCusing female exercisers, female sports performers and their coaches. If the acute moderate-vigorous intensity exercise is performed towards the mid follicular phase, that may cause transient reductions in mucosal immune protection after performing.
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In conclusion, the pattern of salivary SIgA secretion rate response to moderate-vigorous exercise varies across the early and late phases of a monophasic OC cycle. This is associated with fluctuations in resting salivary oestrogen (17β-estradiol)
concentrations. Although the reduction in salivary SIgA responses during the synthetic follicular phase was transient, it may represent a temporary impairment of mucosal immune defence associated with monophasic OC use. 
